Ventures III Lp Aberdare serves as Executive at Conatus Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Ventures III Lp Aberdare has executed 10 insider transactions totaling $1.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 30, 2013 involved exercising options for 1,727 shares valued at $138.
Ventures III Lp Aberdare currently holds 49,712 shares of Conatus Pharmaceuticals Inc (CNAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ventures III Lp Aberdare has been a net buyer of CNAT stock. They have purchased $1.2M and sold $6.2K worth of shares.
Ventures III Lp Aberdare's most recent insider trade was on Jul 30, 2013, when they sold 1,727 shares at $0.08 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 30, 2013 | CNAT | $5.9K | Exercise | 73,395 | $0.08 | Discretionary |
| Jul 30, 2013 | CNAT | $116.8K | Other | 10,614 | $11.00 | Discretionary |
| Jul 30, 2013 | CNAT | $6.1K | Sale | 552 | $11.00 | Discretionary |
| Jul 30, 2013 | CNAT | $154 | Sale | 14 | $11.00 | Discretionary |
| Jul 30, 2013 | CNAT | $2.8K | Other | 251 | $11.00 | Discretionary |
| Jul 30, 2013 | CNAT | $27.2K | Purchase | 2,470 | $11.00 | Discretionary |
| Jul 30, 2013 | CNAT | $0 | Conversion | 1,979,321 | $N/A | Discretionary |
| Jul 30, 2013 | CNAT | $1.2M | Purchase | 104,952 | $11.00 | Discretionary |